| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |